Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor

Name: Expanded Access for LOXO-260 in Participants With Cancer Caused by an Abnormal RET Gene That Did Not Respond/is no Longer Responding to Treatment With a Type of Drug Called a RET Inhibitor
License: Public Domain

Eli Lilly and Company

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

carcinoma

carcinoma, non-small-cell lung, thyroid neoplasms, solid tumors, expanded access

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 848036
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.